← Leaderboards
Jason Becker
Vanderbilt University
$6,034,764
Attributed
$6,034,764
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,034,764 · 5
By mechanism
R01$4,769,662 · 3
K08$667,845 · 1
R56$597,257 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Nancy Joan Brown$32,445,188
- Franz Josef Baudenbacher$1,362,175
- Alfred L George$44,065,377
Others in their field
Top investigators on “Secondary To”
- Randall J Bateman · Washington University$193,862,438
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$140,113,248
- Greg Ulses · Consortium For Ocean Leadership, Inc$140,113,248
- David M Nathan · Massachusetts Institute Of Technology$136,802,550
- Sharon A Nachman · Johns Hopkins University$135,132,510
- John M Lachin · George Washington University$118,672,444
Research focus
Secondary ToHeart FailureHeartPathologicPathway InteractionsSignal PathwayCardiac MyocytesSignal TransductionProteinsMyocardialGeneticHypertrophyHypertrophic CardiomyopathyCellsIn VivoGene MutationCardiacSudden DeathCardiomyopathiesResponsePreventCause Of DeathNon-GeneticMouse Model
Grant awards (17)
MDM2-HIF signaling in pathological ventricular remodeling$744,195
R01 · FY2025 · HL · contact PI
Cardiomyocyte selective modulation of natriuretic peptide signaling in cardiomyopathy$653,854
R01 · FY2025 · HL · contact PI
MDM2-HIF signaling in pathological ventricular remodeling$744,195
R01 · FY2024 · HL · contact PI
Cardiomyocyte selective modulation of natriuretic peptide signaling in cardiomyopathy$653,854
R01 · FY2024 · HL · contact PI
MDM2-HIF signaling in pathological ventricular remodeling$597,257
R56 · FY2022 · HL · contact PI
Cell State Specific modifiers of pathological cardiac remodeling$391,411
R01 · FY2021 · HL · contact PI
Cell State Specific modifiers of pathological cardiac remodeling$391,411
R01 · FY2020 · HL · contact PI
Cell State Specific modifiers of pathological cardiac remodeling$400,742
R01 · FY2019 · HL · contact PI
Cell State Specific modifiers of pathological cardiac remodeling$275,403
R01 · FY2018 · HL · contact PI
Cell State Specific Modifiers of Pathological Cardiac Remodeling$119,597
R01 · FY2018 · HL · contact PI
Cell State Specific Modifiers of Pathological Cardiac Remodeling$395,000
R01 · FY2017 · HL · contact PI
The role of Raf-MEK signaling in the pathogenesis of hypertrophic cardiomyopathy$145,800
K08 · FY2017 · HL · contact PI
The role of Raf-MEK signaling in the pathogenesis of hypertrophic cardiomyopathy$145,800
K08 · FY2016 · HL · contact PI
The role of Raf-MEK signaling in the pathogenesis of hypertrophic cardiomyopathy$108,866
K08 · FY2015 · HL · contact PI
The role of Raf-MEK signaling in the pathogenesis of hypertrophic cardiomyopathy$16,549
K08 · FY2015 · HL · contact PI
The role of Raf-MEK signaling in the pathogenesis of hypertrophic cardiomyopathy$125,415
K08 · FY2014 · HL · contact PI
The role of Raf-MEK signaling in the pathogenesis of hypertrophic cardiomyopathy$125,415
K08 · FY2013 · HL · contact PI